The early-stage VC firm transforms the University of Oxford's scientific research into businesses across life sciences, healthtech, and deeptech.
Under the non-binding agreement, O3 may increase its ownership in the social impact investor if certain fund launch and fundraising milestones are met.
Salica Investments also participated in the secondary share sale, which valued the UK-based wealth management platform at $1.1 billion.
The digital bank has reportedly kicked off its employee liquidity event, pricing shares at $2,017 each.
The transaction delivered returns of up to 34x for certain shares while allowing SFC to retain 70% of its position in the premium wellness consumer brand.
The GP stakes deal builds on a 2024 strategic partnership, which established Lazard Elaia Capital as a technology-focused private equity investment platform.
The direct secondary deals cover stakes in more than 14 businesses held by bp Ventures and Trifork Labs.
The secondary sale will value the UK wealth management platform at approximately £800 million ($1.1 billion), a 45% increase from its 2024 mark.
The deal would reportedly double the AI-voice startup's $11 billion valuation set during a February fundraise.
The transaction intends on providing the VC investor with significant capital for new investments and support for the continued growth of its existing portfolio.
